Article

BRAFnon-V600E more frequently co-occurs with IDH1/2 mutation in adult patients with gliomas than patients harboring BRAFV600E, but without survival advantage

2021-03-02

Abstract excerpt

<title>Abstract</title> Background The effect of <italic>BRAF</italic>non−V600E and <italic>BRAF</italic>V600E on the outcome and the molecular characteristics in adult glioma patients is unknown and needs to be explored, although <italic>BRAF</italic>V600E has been extensively studied in pediatric glioma. Methods Co-occurring mutations and copy number alterations of associat...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 201c0edf-bf28-5256-bd9c-62b06a2388ed
DOI: 10.21203/rs.3.rs-279542/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

BRAFnon-V600E more frequently co-occurs with IDH1/2 mutation in adult patients with gliomas than patients harboring BRAFV600E, but without survival advantageDOI 10.21203/rs.3.rs-279542/v1Read

BRAFnon-V600E more frequently co-occurs with IDH1/2 mutations in adult patients with gliomas than in patients harboring BRAFV600E but without a survival advantage.Semantic proximity Read

BRAFAMP Frequently Co-occurs With IDH1/2, TP53, and ATRX Mutations in Adult Patients With Gliomas and Is Associated With Poorer Survival Than That of Patients Harboring BRAFV600ESemantic proximity Read

Integrated molecular and clinical analysis of BRAF-mutant glioma in adultsSemantic proximity Read

Additional genetic alterations in BRAF-mutant gliomas correlate with histologic diagnoses.Semantic proximity Read

IDH-mutant gliomas with additional class-defining molecular events.Semantic proximity Read

Updates on the WHO diagnosis of IDH-mutant glioma.Semantic proximity Read

A review of recently described genetic alterations in central nervous system tumors.Semantic proximity Read

Molecular Heterogeneity in BRAF-Mutant Gliomas: Diagnostic, Prognostic, and Therapeutic ImplicationsSemantic proximity Read

Structural variants shape driver combinations and outcomes in pediatric high-grade gliomaSemantic proximity Read

Prevalence of class I-III BRAF mutations among 114,662 cancer patients in a large genomic database.Semantic proximity Read

Unraveling BRAF alterations: molecular insights to circumvent therapeutic resistance across cancer typesSemantic proximity Read

Journal of Neuro Oncology: Diagnostic and therapeutic implications of IDH mutations in gliomas following the 2021 World Health Organization classification of CNS tumors.Semantic proximity Read